JANSSEN ALZHEIMER IMMUNOTHERAPY;NEURALAB LIMITED;CRIMAGUA LIMITED;ELAN PHARMA INTERNATIONAL LTD.
发明人:
申请号：
IL19190408
公开号：
IL191904A
申请日:
2008.06.03
申请国别(地区):
IL
年份:
2014
代理人:
摘要：
The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A² peptide or an antibody thereto.
